January 21, 2011 — New data showing nonsteroidal anti-inflammatory drugs (NSAIDs) have cardiovascular risks are putting the well-known pain relievers back in the headlines. Investigators evaluating available evidence report they have found little to suggest…
The antidepressant citalopram should not be used in doses higher than 40 mg per day because of concerns that it can cause potentially fatal changes in heart rhythm, the US Food and Drug Administration warns.…
Activated drotrecogin alfa is a recombinant form of human activated protein C. It was approved by the US Food and Drug Administration (FDA) nearly a decade ago to lower mortality rates in adults with severe…
The U.S. Food and Drug Administration (FDA) has added a Boxed Warning to the label for Plavix, the anti-blood clotting medication. The Boxed Warning is about patients who do not effectively metabolize the drug (i.e.…

Introduction

The  Hospital Pharmacists Association of Kenya (HOPAK) provides a dynamic platform for the exchange of knowledge among sector players to enhance their contributions to health. We provide timely scientific programs, ongoing education, opportunities for networking, and professional development.

Our website is a resource portal for all practicing hospital and institutional pharmacists in Kenya.

Contact us

Hospital Pharmacists Association of Kenya (HOPAK)
P. O. Box 19859 00202
Nairobi - Kenya
info@hopak.or.ke